Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: Direct measurements using [3H]epibatidine

Brain Research

Volumn 974, Issue 1-2, 2003, Pages 60-69

  Free, R Benjamin ^a   McKay, Dennis B ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Adrenal; Epibatidine; Nicotinic receptor; Receptor binding; 3; 4

Indexed keywords

CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; EPIBATIDINE H 3; NICOTINE; NICOTINIC RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL SURFACE; CHROMAFFIN CELL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; ROOM TEMPERATURE;

EID: 0037988938     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02551-4     Document Type: Article

References (26)

1. Cordero-Erausquin M., Marubio L.M., Klink R., Changeux J.-P. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol. Sci. 21:2000;211-217.
2. 3H]Epibatidine binding to bovine adrenal medulla: evidence for α3β4* nicotinic receptors. Neurosci. Lett. 318:2002;98-102.
3. Free R.B., McKay D.B. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors. Brain Res. 891:2001;176-184.
4. Free R.B., Wenger B.W., McKay D.B. Effects of sulfhydryl modification on adrenal nicotinic acetylcholine receptors: disulfide integrity is not essential for activation. Life Sci. 68:2000;373-385.
5. Gu H., Wenger B.W., Lopez I., McKay S.B., Boyd R.T., McKay D.B. Characterization and localization of adrenal nicotinic receptors: evidence that mAb35-nicotinic receptors are the principal receptors mediating adrenal catecholamine release. J. Neurochem. 66:1996;1454-1461.
6. Guan Z.Z., Zhang X., Ravid R., Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J. Neurochem. 74:2000;237-243.
7. Jacob M.H., Lindstrom J.M., Berg D.K. Surface and intracellular distribution of a putative neuronal nicotinic acetylcholine receptor. J. Cell Biol. 103:1986;205-214.
8. Jones S., Sudweeks S., Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci. 22:1999;555-561.
9. Livett B.G. Adrenal medullary chromaffin cells in vitro. Physiol. Rev. 64:1984;1103-1161.
10. Lukas R.J., Changeux J.-P., le Novère N., Albuquerque E.X., Balfour J.K., Berg D.K., Bertrand D., Chiappinelli V.A., Clarke P.B.S., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quik M., Taylor P.W., Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51:1999;397-401.
11. Maurer J.A., McKay D.B. Staurosporine-induced reduction of secretory function in cultured bovine adrenal chromaffin cells. Eur. J. Pharmacol. 253:1994;115-124.
12. ++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine. J. Pharmacol. Exp. Ther. 231:1984;102-108.
13. Merlie J.P., Lindstrom J. Assembly in vivo of mouse muscle acetylcholine receptor: Identification of an α subunit species that may be an assembly intermediate. Cell. 34:1983;747-757.
14. Peng X., Gerzanich V., Anand R., Wang F., Lindstrom J. Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51:1997;776-784.
15. Picciotto M.R., Caldarone B.J., King S.L., Zachariou V. Nicotinic receptors in brain: links between molecular biology and behavior. Neuropsychopharmacology. 22:2000;452-465.
16. Richardson C.E., Morgan J.M., Jasani B., Green J.T., Rhodes J., Williams G.T., Lindstrom J., Wonnacott S., Thomas G.A.O., Smith V. Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit. Gastroenterology. 121:2001;350-357.
17. Sershen H., Balla A., Lajtha A., Vizi E.S. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience. 77:1997;121-130.
18. Sine S., Taylor P. Functional consequences of agonist-mediated state transitions in the cholinergic receptor. J. Biol. Chem. 254:1979;3315-3325.
19. Stauderman K.A., Mahaffy L.S., Akong M., Velicelebi G., Chavez-Noriega L.E., Crona J.H., Johnson E.C., Elliot K.J., Gillespie A., Reid M.T., Adams P., Harpold M.M., Corey-Naeve J. Characterization of human recombinant neuronal nicotinic acetylcholine receptors subunit combinations of α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J. Pharmacol. Exp. Ther. 284:1998;777-789.
20. Stollberg J., Berg D.K. Neuronal acetylcholine receptors: fate of surface and internal pools in cell culture. J. Neurosci. 7:1987;1809-1815.
21. Trifaro J.M. Cellular and molecular mechanisms in hormone and neurotransmitter secretion. Can. J. Physiol. Pharmacol. 68:1990;1-16.
22. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. New Engl. J. Med. 343:2000;847-855.
23. Wenger B.W., Bryant D.L., Boyd R.T., McKay D.B. Evidence for spare nicotinic acetylcholine receptors and a β4 subunit in bovine adrenal chromaffin cells: Studies using bromoacetylcholine, epibatidine, cytisine, and mAb35. J. Pharmacol. Exp. Ther. 281:1997;905-913.
24. Whiteaker P., Sharples C.G.V., Wonnacott S. Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol. Pharmacol. 53:1998;950-962.
25. Xiao Y., Meyer E.L., Thompson J.M., Surin A., Wroblewski J., Kellar K.J. Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol. Pharmacol. 54:1998;322-333.
26. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., Beaudet A.L. Megacystis, mydriasis and ion channel defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA. 96:1999;5746-5751.